Joel M. Kremer
Expertise in
5
conditions

Dr. Joel M. Kremer

Rheumatology
4 Tower Pl, 8th Floor, 
Albany, NY 
47 Years of Experience
Expertise in
5
conditions
4 Tower Pl, 8th Floor, 
Albany, NY 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Joel Kremer is a Rheumatologist in Albany, New York. Dr. Kremer has been practicing medicine for over 47 years is highly rated in 5 conditions, according to our data. His top areas of expertise are Rheumatoid Arthritis (RA), Arthritis, Psoriatic Arthritis, Psoriasis, and Laminectomy.

His clinical research consists of co-authoring 221 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Rheumatology
Licenses
Specialist in NY
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

4 Tower Pl, 8th Floor, Albany, NY 12203

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
A Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Methotrexate Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Phase: Phase 3
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
A Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Phase III Study of the Efficacy and Safety of Olokizumab in Subjects With Moderately to Severely Active Rheumatoid Arthritis Inadequately Controlled by Tumor Necrosis Factor Alpha (TNF-α) Inhibitor Therapy
Enrollment Status: Completed
Publish Date: September 21, 2023
Intervention Type: Drug
Study Drug: Olokizumab
Study Phase: Phase 3
Treatments Against RA and Effect on FDG-PET/CT (The TARGET Trial)
Treatments Against RA and Effect on FDG-PET/CT (The TARGET Trial)
Enrollment Status: Completed
Publish Date: October 26, 2022
Intervention Type: Drug
Study Drugs: Methotrexate, Sulfasalazine, Hydroxychloroquine, Etanercept, Adalimumab
Study Phase: Phase 4
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
A Multicenter, Long-Term Extension Study of 104 Weeks, Including a Double-Blind, Placebo-Controlled 40-Week Randomized Withdrawal-Retreatment Period, to Evaluate the Maintenance of Treatment Effect of Ixekizumab (LY2439821) in Patients With Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 13, 2022
Intervention Type: Drug
Study Phase: Phase 3
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Safety and Effectiveness of Live Zoster Vaccine in Anti-TNF Users (VERVE Trial)
Enrollment Status: Completed
Publish Date: November 23, 2021
Intervention Type: Drug, Biological
Study Drug: Zostavax Herpes Zoster Vaccine
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Placebo- Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in TNFi-Experienced Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: June 17, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis
Enrollment Status: Completed
Publish Date: November 19, 2019
Intervention Type: Drug
Study Phase: Phase 3
View 6 Less Clinical Trials

224 Total Publications

Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipins.
Disease response in rheumatoid arthritis across four biologic therapies associates with improvement in paraoxonase-1 activity and oxylipins.
Journal: RMD open
Published: August 02, 2024
Similar Doctors
Expertise in
15
conditions
Dr. Lee S. Shapiro
Rheumatology
Expertise in
15
conditions
Dr. Lee S. Shapiro
Rheumatology
1 West Ave Ste 330, 
Saratoga Springs, NY 
 (27.3 miles away)
518-782-3899
Languages Spoken:
English
See accepted insurances

Lee Shapiro is a Rheumatologist in Saratoga Springs, New York. Dr. Shapiro is highly rated in 15 conditions, according to our data. His top areas of expertise are Scleroderma, Systemic Sclerosis (SSc), Scleroma, and Scleredema.

Expertise in
37
conditions
Dr. Dorota L. Hausner-Sypek
Rheumatology
Expertise in
37
conditions
Dr. Dorota L. Hausner-Sypek
Rheumatology

The Center For Rheumatology Llp

4 Tower Pl, Fl 8, 
Albany, NY 
 (0.1 miles away)
518-489-4471
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Dorota Hausner-Sypek is a Rheumatologist in Albany, New York. Dr. Hausner-Sypek is highly rated in 37 conditions, according to our data. Her top areas of expertise are Rheumatoid Lung Disease, Rheumatoid Pneumoconiosis, Rheumatoid Vasculitis, and Ankylosing Spondylitis.

Expertise in
25
conditions
Dr. Edmund H. Hornstein
Rheumatology
Expertise in
25
conditions
Dr. Edmund H. Hornstein
Rheumatology

Berkshire Medical Center Inc

725 N St, 
Pittsfield, MA 
 (34.0 miles away)
413-447-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Edmund Hornstein is a Rheumatologist in Pittsfield, Massachusetts. Dr. Hornstein is highly rated in 25 conditions, according to our data. His top areas of expertise are Osteoporosis, Postmenopausal Osteoporosis, Rheumatoid Arthritis (RA), and Undifferentiated Connective Tissue Disease (UCTD). Dr. Hornstein is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kremer's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile